Walleye Trading
PPH icon

Walleye Trading’s VanEck Pharmaceutical ETF PPH Stock Holding History

Walleye Trading’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2
Closed – – 4307
2014
Q2 		$0 Sell
2
-298
-99% -$17.7K ﹤0.01% 3975
2014
Q1 		$18 Buy
+300
New +$17K ﹤0.01% 3084

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Walleye Trading's PPH Position: Q3 2014 in Review

Walleye Trading sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2014, closing a stake of 2 shares.

Walleye Trading first reported a position in PPH in Q1 2014 and held it in 2 quarters. The position peaked at $18 in Q1 2014. 49 funds tracked by Wall St. Rank hold PPH as of Q3 2014.

  • Walleye Trading reported no remaining VanEck Pharmaceutical ETF position as of Q3 2014 after selling out during the quarter.
  • Walleye Trading sold 2 VanEck Pharmaceutical ETF shares in Q3 2014.
  • Walleye Trading first reported a position in VanEck Pharmaceutical ETF in Q1 2014 and held it in 2 quarters.
  • Walleye Trading's VanEck Pharmaceutical ETF position peaked at $18 in Q1 2014.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2014.

Based on Walleye Trading's 13F filing for Q3 2014, filed 14 Nov 2014.